Real-world data (RWD) is information collected outside of traditional clinical trials. It shows how patients use treatments and the outcomes they report in everyday life.
At Curaleaf Clinic, patients can choose to contribute to the UK Medical Cannabis Registry, which collects RWD on patient outcomes. This registry — the largest of its kind in Europe — gathers anonymised, consented information to help improve understanding of medical cannabis in the UK.
Real-world data (RWD) is health-related information collected from patients during routine care, rather than in the strict and controlled conditions of a clinical trial (where participants are closely monitored and follow a set protocol). This type of data shows how treatments are used and experienced by people in their daily lives.
In healthcare, RWD can come from a variety of sources such as electronic health records, patient surveys, or registries.
At Curaleaf Clinic, we contribute to the UK Medical Cannabis Registry, which collects anonymised data from patients prescribed medical cannabis. This information can help guide better treatment choices and improve patient care.
RWD is valuable because it helps doctors, researchers, and regulators understand how treatments work outside of clinical trials. For medical cannabis, where traditional large-scale clinical trials are still limited, real world data can help offer important insights into patient safety, effectiveness, and quality of life. By contributing to the UK Medical Cannabis Registry, Curaleaf Clinic patients are helping shape future research and improve access to safe, evidence-based care.